<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of this retrospective study was to assess respiratory and cardiac function in a large cohort of patients with <z:hpo ids='HP_0003741'>congenital muscular dystrophies</z:hpo> (CMD) with reduced glycosylation of alphadystroglycan (Î±-DG) </plain></SENT>
<SENT sid="1" pm="."><plain>Thirteen of the 115 patients included in the study died between the age of 1 month and 20 years </plain></SENT>
<SENT sid="2" pm="."><plain>The age at last follow up of the surviving 102 ranged between 1 year and 68 years (median: 9.3 years) </plain></SENT>
<SENT sid="3" pm="."><plain>Cardiac involvement was found in 7 of the 115 (6%), 5 with <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo>, 1 <z:hpo ids='HP_0011675'>cardiac conductions defects</z:hpo> and 1 <z:hpo ids='HP_0001653'>mitral regurgitation</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Respiratory function was impaired in 14 (12%) </plain></SENT>
<SENT sid="5" pm="."><plain>Ten of the 14 required non invasive nocturnal respiratory support, while the other four required invasive ventilation </plain></SENT>
<SENT sid="6" pm="."><plain>Cardiac or respiratory involvement was found in patients with mutations in FKRP, POMT1, POMT2 </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> of the patients in whom mutation in POMGnT1 were identified had <z:mpath ids='MPATH_458'>normal</z:mpath> cardiac and respiratory function </plain></SENT>
</text></document>